Two-step approach for the prediction of future type 2 diabetes risk

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 2108-2112

  Abdul Ghani, Muhammad A ^a   Abdul Ghani, Tamam ^a   Stern, Michael P ^a   Karavic, Jasmina ^b   Tuomi, Tiinamaija ^b   Bo, Insoma ^b   DeFronzo, Ralph A ^a   Groop, Leif ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREDICTIVE VALUE; RISK ASSESSMENT; SAN ANTONIO DIABETES PREDICTION MODEL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; BLOOD; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84858606982     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2201     Document Type: Article

References (25)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431 (Pubitemid 28405191)
2. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008;31:1-20
3. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
4. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
5. Gerstein HC, Yusuf S, Bosch J, et al.; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-1105
6. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007;78:305-312 (Pubitemid 350030320)
7. Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-723 (Pubitemid 35013848)
8. Dankner R, Abdul-Ghani MA, Gerber Y, Chetrit A, Wainstein J, Raz I. Predicting the 20-year diabetes incidence rate. Diabetes Metab Res Rev 2007;23:551-558 (Pubitemid 350018029)
9. Abdul-Ghani MA, Williams K, Stern MP, DeFronzo R. A Risk of progression to type 2 diabetes upon the relationship between the post-load plasma glucose and fasting plasma glucose concentrations. Diabetes Care 2006;29:1613-1618 (Pubitemid 44127589)
10. Mann DM, Bertoni AG, Shimbo D, et al. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2010;171:980-988
11. Stern M, Williams K, Eddy D, Kahn R. Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models. Diabetes Care 2008;31:1670-1671
12. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 2003;26:758-763 (Pubitemid 36929340)
13. Eschwège E, Charles MA, Simon D, Thibult N, Balkau B; Paris Prospective Study. Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001; 24:1941-1944 (Pubitemid 33716505)
14. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-581 (Pubitemid 34407041)
15. Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006;29:1872-1877 (Pubitemid 44156645)
16. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650 (Pubitemid 41785063)
17. Kanaya AM, Wassel Fyr CL, de Rekeneire N, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 2005;28:404-408 (Pubitemid 40170947)
18. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731 (Pubitemid 36929335)
19. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern MP. What is the best predictor of future type 2 diabetes? Diabetes Care 2007;30:1544-1548 (Pubitemid 46871168)
20. Abdul-Ghani MA, Abdul-Ghani TA, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008;31:1650-1655
21. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009;32:281-286
22. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 1984;120:834-851 (Pubitemid 15216798)
23. Groop L, Forsblom C, Lehtovirta M, et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996;45:1585-1593 (Pubitemid 26357553)
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
25. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 2007;24:137-144